The United Kingdom licensed the synthetic cannabinoid nabilone for treating side effects from cancer chemotherapy. It restored narrow legal access to a cannabis-based medicine, while herbal cannabis remained prohibited.[1]
Score by segment 0 to 10
- Possession · 25%1 → 1
- Personal cultivation · 25%1 → 1
- Punishment & enforcement · 20%3 → 3
- Sharing & gifting · 10%1 → 1
- Consumption · 10%1 → 1
- Legal access · 10%0 → 1+1
The bar shows the score after the change; the tick marks where it stood before. United Kingdom's scores have changed again since.
References
- Forces of Necessity: Lay Advocacy and the Remedicalization of Cannabis in the UK, 1973–2004Suzanne Taylor · In Cannabis: Global Histories, edited by Lucas Richert, James H. Mills · MIT Press · 2021 · pp. 341–361 · ISBN 9780262366137
Checked. The date and the event were compared with a source that was read. The score before the change is an editorial estimate.